Diabetic Retinopathy and Calcium Dobesilate Annapolis MD

Read more about Diabetic Retinopathy and Calcium Dobesilate.

Douglas D Dykman, MD
(410) 224-2116
820 Bestgate Rd
Annapolis, MD
Business
Anne Arundel Gastroenterology Associates
Specialties
Gastroenterology, Gastroscopy--colonoscopy--ERCP--Nutrional Counseling--Gut Cam/Capsule Endoscopy--Esophogeal pH monitoring--motility studies--clinical research studies
Doctor Information
Residency Training: The Jewish Hospital of St Louis/ Washington University
Medical School: Washington University,

Data Provided by:
William Cassidy, MD
(410) 224-2116
820 Bestgate Rd
Annapolis, MD
Business
Anne Arundel Gastroenterology Assoc.
Specialties
Gastroenterology
Doctor Information
Primary Hospital: AAMC
Residency Training: Georgetown Service at DC General
Medical School: Loyola Stritch School of Medicine,

Data Provided by:
Greater Annapolis Veterinary Hospital
(410) 224-3800
1901 Generals Hwy
Annapolis, MD

Data Provided by:
Donna G Chambers MD
(410) 573-0140
133 Defense Hwy
Annapolis, MD
Specialties
Internal Medicine

Data Provided by:
O'Brien Chiropractic Ctr
(410) 268-8496
1912 Lincoln Dr
Annapolis, MD

Data Provided by:
Charles Cattano, MD
(410) 224-2116
820 Bestgate Rd
Annapolis, MD
Business
Anne Arundel Gastroenterology Associates
Specialties
Gastroenterology, Gastroscopy--colonoscopy--ERCP--Nutrional Counseling--Gut Cam/Capsule Endoscopy--Esophogeal pH monitoring--motility studies--clinical research studies---------Pediatric Gastroenterology
Doctor Information
Primary Hospital: AAMC
Residency Training: Northewestern University
Medical School: Upstate Medical Center, Syracuse,

Data Provided by:
Living Health Chiropractic
(410) 216-9180
1833 Forest Dr # A
Annapolis, MD

Data Provided by:
Paul Buhrer
(410) 841-5355
2448 Holly Avenue
Annapolis, MD
Specialties
Cosmetic Surgery
Insurance
Medicare Accepted: No
Workmens Comp Accepted: No
Accepts Uninsured Patients: No
Emergency Care: No


Data Provided by:
John L. Newman, MD
(410) 224-2116
820 Bestgate Rd
Annapolis, MD
Business
Anne Arundel Gastroenterology Associates
Specialties
Gastroenterology, Gastroscopy--colonoscopy--ERCP--Nutrional Counseling--Gut Cam/Capsule Endoscopy--Esophogeal pH monitoring--motility studies--clinical research studies
Doctor Information
Residency Training: West Virginia University
Medical School: University of Maryland,

Data Provided by:
Michael N. Peters, MD
(410) 224-2116
820 Bestgate Rd
Annapolis, MD
Business
Anne Arundel Gastroenterology Associates
Specialties
Gastroenterology
Doctor Information
Primary Hospital: AAMC
Medical School: Baylor College of Medicine,

Data Provided by:
Data Provided by:

Diabetic Retinopathy and Calcium Dobesilate

Diabetic Retinopathy and Calcium Dobesilate.
Date: Wednesday, May 27, 2009
Source: The Lancet
Related Monographs: Diabetes Mellitus, Type 2
Natural Health Information that is accurate, objective, science-based and represents the current state of research is the most sought-after information category today. Natural Health Information On Demand, NHIOndemand, is the leading source for this valuable science-based natural health information.
©2000-2009 CCG, Inc. All Rights Reserved.

Diabetic retinopathy is retinopathy (damage to the retina) caused by complications of diabetes mellitus, which can eventually lead to blindness.  It is the most common diabetic eye disease and affects up to 80% of all patients who have had diabetes for 10 years or more. Small blood vessels - such as those in the eye - are especially vulnerable to poor blood sugar (blood glucose) control which could cause an over accumulation of glucose and/or fructose damaging the tiny blood vessels in the retina. During the initial stage, called nonproliferative diabetic retinopathy (NPDR), most people do not notice any change in their vision. In the United States, diabetic retinopathy is the leading cause of blindness in adults. All people with diabetes mellitus are at risk - those with type 1 diabetes (juvenile onset) and those with type 2 diabetes (adult onset). Between 40 to 45 percent of Americans diagnosed with diabetes have some stage of diabetic retinopathy.

Calcium dobesilate, also known as 2,5-dihydroxybenzene sulfonate, is a drug commonly used in the treatment of diabetic retinopathy and chronic venous insufficiency. The pharmacology of calcium dobesilate reveals its ability to decrease capillary permeability, as well as platelet aggregation (clumping together of platelets) and blood viscosity (a measure of the resistance of blood to flow).

A multi-center randomized, double-blind and placebo controlled study assessed the effect of calcium dobesilate on the occurrence of diabetic macular edema. The study, which took place in 40 different centers in 11 countries, enrolled 635 patients with type 2 diabetes and mild-to-moderate non-proliferative diabetic retinopathy. The patients were then randomly selected to receive either calcium dobesilate or a placebo. Clinically significant macular edema (CSME) developed in 86 of the 324 people who took calcium dobesilate and in 69 of the 311 who took the placebo. It was determined that people who took the drug were 32 percent more likely to develop CSME than those who took the placebo. This information suggests that calcium dobesilate could neither prevent the occurrence of macular edema nor reduce the probability of developing it. The researchers concluded that the best way to prevent diabetic blindness is by implementing systemic screenings for diabetic retinopathy and preventive laser treatment for those who develop macular edema or proliferative retinopathy.1  

1 Haritoglou C, Gerss J, Sauerland C, et al. Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial. The Lancet. 2009;373(9672):1364-1371.

This information is educational in context and is not to be used to diagnose, treat or cure any disease. Please consult your licensed health care practitioner before using this or any medical information.
©2000-2009 CCG, Inc. All Rights Reserved.